NCT05635747
A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB
Enrolling by Invitation
Not specifiedAges 2–18ObservationalBoston Children's HospitalInvestigator-initiated
~32 participants
Updated 2026-07-06 on ClinicalTrials.gov
What's tested:Relizorb Enzyme Cartridge
At a glance
Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
To evaluate the effect of the RELiZORB enzyme cartridge when used with enteral nutrition daily for an additional 90 days
Measured over 90 days
Conditions
NCT05635747
Where you'd take part
This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Boston Children's Hospital
Boston, Massachusettsno site contact published
Children's Hospital Los Angeles
Los Angeles, Californiano site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Mark Puder, MD, PhD · PRINCIPAL_INVESTIGATOR · Boston Children's Hospital
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- To evaluate the effect of the RELiZORB enzyme cartridge when used with enteral nutrition daily for an additional 90 days90 days
change from baseline in PN calories